Biocept, Inc.
BIOCQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -34.84M | -41.26M | -36.32M | -29.58M | -15.85M |
| Total Depreciation and Amortization | 1.83M | 1.45M | 1.66M | 554.00K | 908.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -515.00K | 1.86M | 3.30M | 4.65M | 5.23M |
| Change in Net Operating Assets | 15.93M | 19.40M | 18.08M | 16.89M | 5.62M |
| Cash from Operations | -17.60M | -18.55M | -13.29M | -7.48M | -4.09M |
| Capital Expenditure | -680.00K | -800.00K | -807.00K | -1.26M | -1.06M |
| Sale of Property, Plant, and Equipment | 75.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -605.00K | -800.00K | -807.00K | -1.26M | -1.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.19M | -2.08M | -2.11M | -1.81M | -1.69M |
| Issuance of Common Stock | 4.10M | 636.00K | 240.00K | 879.00K | 10.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.91M | -1.44M | -1.87M | -933.00K | 8.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.30M | -20.79M | -15.97M | -9.68M | 3.48M |